Stay updated on CDX-0159 Phase 1 Clinical Trial
Sign up to get notified when there's something new on the CDX-0159 Phase 1 Clinical Trial page.

Latest updates to the CDX-0159 Phase 1 Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.2%
- Check42 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a study on CDX-0159, including its purpose, methodology, and inclusion/exclusion criteria. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference21%
- Check49 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.2%
- Check93 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference3%
- Check107 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference3%
- Check114 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.2%
Stay in the know with updates to CDX-0159 Phase 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-0159 Phase 1 Clinical Trial page.